Searched for
MERCK COVID
Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Ebola outbreak sparks concern in India, US: Should you be worried? Here's what you need to know about signs, symptoms and preventionEbola in India: The WHO has declared the Ebola outbreak in Congo and Uganda a public health emergency with over 300 cases and 88 deaths. In...
- Moderna first-quarter revenue jumps on strong overseas COVID vaccine salesModerna's first-quarter revenue surpassed estimates, driven by strong international COVID-19 vaccine sales. The company forecasts lower-tha...
- Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
- How does Merck's COVID-19 pill compare to Pfizer's?Merck in November said its full trial results showed that molnupiravir lowered the chance of hospitalization or death by about 30% in patie...
- Domestic pharma companies gear up to launch Merck's Covid pillUnion health minister Mansukh Mandaviya said 13 companies in India will manufacture the drug approved for restricted use under emergency si...
- U.S. FDA authorizes Merck's at-home antiviral COVID-19 pillMerck's drug, molnupiravir, developed with Ridgeback Biotherapeutics, was shown to reduce hospitalizations and deaths by around 30% in a cl...
- Final US hurdle for Merck's COVID-19 pill: FDA panel reviewIf authorized, Merck's pill would be the first that U.S. patients could take at home to ease symptoms and speed recovery, a major step towa...
- UK authorizes Merck's coronavirus pill, the first shown to be effective at treating COVID-19The pill was licensed for adults 18 and older who have tested positive for COVID-19 and have at least one risk factor for developing severe...
- India's Everest Organics starts making ingredient for Merck's COVID-19 pillThe Indian bulk drugs manufacturer joins Divi's Laboratories Ltd as an API maker for Merck's experimental oral drug. Merck has separately e...
- Two Indian drugmakers seek to end trials of Merck's antiviral drug for moderate COVID-19The two Indian drugmakers, Aurobindo Pharma and MSN Laboratories plan to continue late-stage trails of the drug for those with mild COVID-1...
- Place bulk orders for Merck's Covid pillThe trials show that the pill halved the chances of hospitalisation in Covid-19 patients with mild or moderate form of the disease.
- How good is Merck's new Covid pill?For more such web stories click on the ET icon below
- What you need to know about Merck’s new COVID treatment medicineThe pills are meant for people who are sick with COVID but are not in the hospital.
- Merck to seek emergency approval for experimental pill that cuts worst effects of coronavirusIf cleared, Merck's drug - molnupiravir - would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight ...
- Oral Covid treatment yields promising trial data: DrugmakersIn January, Merck halted work on two Covid vaccine candidates but has pressed on with research into two products to treat the disease, incl...
- Merck ends development of two potential COVID-19 vaccinesThe drugmaker said Monday that it will focus instead on studying two possible treatments for the virus that also have yet to be approved by...
- Merck leaps into COVID-19 development fray with vaccine, drug dealsIt also announced a partnership with privately-held Ridgeback Biotherapeutics to develop an experimental oral antiviral drug against COVID-...
Load More
